Global Injection Pen Market is Estimated to Value Over USD 68.2 Billion by 2026 End

  • 02 Oct 2019

Global Injection Pen Market is estimated to value over USD 68.2 billion by 2026 end and register a CAGR of over 9% during the forecast period 2019 to 2026.


With chronic diseases being so common and the increased usage of such a product, the injection pen market is expected to grow substantially. Furthermore, there is a strong need for self-medication as it allows patients maximum flexibility and autonomy. In addition, injection pen devices are sanctioned and regulated by the FDA, thereby, making them safe to use. It is also worth noting that there are significant government provisions and positive healthcare schemes in developing and developed nations alike, which have been contributing factors in the global injection pen market growth. Furthermore, recent developments in injection pen tools such as smaller dosing capacity, automated needle injections and the usage of needle safety tools have paved the way for opportunities in the market. However, there is a preference for alternative drug delivery methods and the lack of positive reimbursement in developing countries may negatively impact the growth of the injection pen market.


The demand for injection pens is anticipated to augment the growth of the market due to the growing presence of chronic diseases on a global scale, a rise in approvals and sanctions by regulatory bodies, as well as considerable reimbursements. However, the scenario is different in the developing nations as there is a tendency to opt for alternative drug delivery methods and the relatively low reimbursement are factors which could pose hindrances to the market potential. 


The regions of Europe and North America have captured the market for injection pen. Technological innovations, support from the FDA, as well as the growing research and development activities are some factors which have augmented the growth of the market. In addition, the high number of diabetes related cases, along with the geriatric population are aspects which are expected to drive the market growth in the region of Asia Pacific. The countries of Japan, China and India are noted to be large contributors to this market.


Major players in the global injection pen market are Ypsomed (Switzerland), Sanofi (France), Owen Mumford (UK), Haselmeier (Switzerland), Merck (US), Becton Dickinson and Company (US), Eli Lilly (US), F.Hoffman-La Roche (Switzerland), AstraZeneca (UK), Pfizer (US), Novartis (Switzerland).


Global Injection Pen Market Segmentation:

By Dosage Type:

  • Fixed
  • Variable                 

By Application

  • Diabetes
  • Insulin
  • Non-insulin
  • Anaphylaxis
  • Osteoporosis
  • Growth hormone deficiency
  • Arthritis
  • Others                   

By Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East & Africa


FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth


Objectives of the Study:

  • To provide with an exhaustive analysis on the global injection pen market by dosage type, by application, and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions


Get unlimited analyst support and customise this study further to your requirements, contact